A Retrospective Cohort Study on the Preliminary Efficacy of Massage Therapy for Chemotherapy-Induced Peripheral Neuropathy Among Cancer Patients
Open Access
- 1 January 2025
- journal article
- Published by SAGE Publications in Integrative Cancer Therapies
- Vol. 24
Abstract
Purpose: Chemotherapy-induced peripheral neuropathy (CIPN) worsens the quality of life for people with cancer. Massage therapy involves neuromuscular modulations and can potentially reduce CIPN symptoms. We examined the immediate improvements in CIPN-related pain and neuropathy following massage therapy among patients with CIPN. Methods: In a retrospective cohort, we assessed patients who received 1 massage therapy session for CIPN symptom relief during or after chemotherapy at a National Cancer Institute-Designated Comprehensive Cancer Center from October 2017 to September 2022. We measured the severity of pain and neuropathy before and after massage therapy with a 4-item verbal rating scale (VRS) or a 0 to 10 numerical rating scale (NRS). We converted NRS to VRS scores and examined the pre-post differences in symptom severity using the Wilcoxon rank test. Results: Among 23 patients (median [range] age 64 [4-85] years, female 74%, White 70%), one session of massage therapy decreased the percentage of patients reporting moderate-to-severe pain from 81% at baseline to 0% (none) post-massage; percentage of patients reporting neuropathy also reduced from 77% at baseline to 12% following treatment. The pre-post differences were statistically significant for both pain (mean: −1.6, 95% confidence interval [CI] −1.9 to −1.2; P = .001) and neuropathy scores (mean: −1.2, 95%CI −1.4 to −0.9; P < .0001). Conclusion: Among cancer patients with CIPN, one session of massage therapy was associated with immediate neuropathy and CIPN pain relief reported by patients following treatment. However, this preliminary finding requires further rigorous verifications in future randomized controlled clinical trials.Keywords
Funding Information
- NCI (R01 CA251470)
- NCI (R37 CA248563)
- Dana-Farber Cancer Institute (P30 CA008748)
This publication has 40 references indexed in Scilit:
- Frequency, Characteristics, and Reversibility of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With BortezomibJournal of Clinical Oncology, 2006
- Responsiveness of the Numeric Pain Rating Scale in Patients with Low Back PainSpine, 2005
- Postsurgical pain outcome assessmentPain, 2002
- Chemotherapy-induced peripheral neuropathyJournal of Neurology, 2002
- Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scalePain, 2001
- MASSAGE THERAPY AND REFLEXOLOGY AWARENESSNursing Clinics of North America, 2001
- A Comparison of Pain Rating Scales by Sampling From Clinical Trial DataThe Clinical Journal of Pain, 2000
- The visual analogue pain intensity scale: what is moderate pain in millimetres?Pain, 1997
- RELIABILITY OF PAIN SCALES IN THE ASSESSMENT OF LITERATE AND ILLITERATE PATIENTS WITH RHEUMATOID-ARTHRITIS1990
- Studies with pain rating scales.Annals of the Rheumatic Diseases, 1978